Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
Xiangna Zhang, Ana Xu, Jiahui Lv, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111822-111822
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Pattern recognition receptors in health and diseases
Danyang Li, Minghua Wu
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1077
Role of the NLRP3 inflammasome in autoimmune diseases
Zhe Li, Jialong Guo, Liqi Bi
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110542-110542
Open Access | Times Cited: 209
Inflammasome Signaling in Atrial Fibrillation
Amir Ajoolabady, Stanley Nattel, Gregory Y.H. Lip, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 23, pp. 2349-2366
Open Access | Times Cited: 78
Activation and evasion of inflammasomes during viral and microbial infection
Dan Ren, Xiaoou Ye, Ruimin Chen, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 2
Microglial Phenotypic Transition: Signaling Pathways and Influencing Modulators Involved in Regulation in Central Nervous System Diseases
Jiaxin Li, Xinyu Shui, Ruizheng Sun, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 59
Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis
Jiao Yan, Jinshan Nan, Bo Mu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114194-114194
Closed Access | Times Cited: 41
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 38
Inflammasome Molecular Insights in Autoimmune Diseases
Monica Neamţu, Veronica Bild, Alexandru Vasincu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3502-3532
Open Access | Times Cited: 10
Chlorogenic Acid Suppresses miR‐155 and Ameliorates Ulcerative Colitis through the NF‐κB/NLRP3 Inflammasome Pathway
Junhao Zeng, Dengqing Zhang, Xiaoyu Wan, et al.
Molecular Nutrition & Food Research (2020) Vol. 64, Iss. 23
Closed Access | Times Cited: 70
The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
Hana Starobova, Evelyn Israel Nadar, Irina Vetter
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 57
Cellular Models and Assays to Study NLRP3 Inflammasome Biology
Giovanni Zito, Marco Buscetta, Maura Cimino, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4294-4294
Open Access | Times Cited: 56
Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling
Fan Yang, Xun-jia Ye, Mingye Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 53
LncRNA 4344 promotes NLRP3-related neuroinflammation and cognitive impairment by targeting miR‐138-5p
Xiaojin Feng, Fenfang Zhan, Deqiang Luo, et al.
Brain Behavior and Immunity (2021) Vol. 98, pp. 283-298
Closed Access | Times Cited: 50
Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy
Chunren Meng, Chufeng Gu, Shuai He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Inflammasome activation: from molecular mechanisms to autoinflammation
Samuel Lara‐Reyna, Emily A. Caseley, Joanne Topping, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 7
Open Access | Times Cited: 35
Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation
Roberto Iorio, Giuseppe Celenza, Sabrina Petricca
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1199-1199
Open Access | Times Cited: 34
Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome‐mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice
Demei Huang, Shihua Shi, Yilan Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112978-112978
Open Access | Times Cited: 32
Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway
Ling Ou, Hengrui Liu, Xiaoyan Shi, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117428-117428
Closed Access | Times Cited: 19
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer
Valentina Albanese, Sonia Missiroli, Mariasole Perrone, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5223-5241
Closed Access | Times Cited: 17
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 17
Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis
Lídia Perea, Mathieu Bottier, Erin Cant, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 2, pp. 2301966-2301966
Open Access | Times Cited: 7
Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases
Jiasi Wu, Jiayi Sun, Xianli Meng
Pharmacological Research (2021) Vol. 165, pp. 105408-105408
Closed Access | Times Cited: 41
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
Gaber El-Saber Batiha, Ali I. Al‐Gareeb, Damilare Rotimi, et al.
Scientific African (2022) Vol. 18, pp. e01407-e01407
Open Access | Times Cited: 28
Structure-based design and synthesis of sulfonylureas as novel NLRP3 inhibitors for Alzheimer’s disease
Eun Young Kim, Jae Hong Im, Jinhe Han, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129622-129622
Closed Access | Times Cited: 5
Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
Min Zhao, Neng Ye, Ling Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7516-7538
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top